Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Rituximab × Clear all

Sponsor

Conditions

Lymphoma 171 Lymphoma, Non-Hodgkin 155 Leukemia, Lymphocytic, Chronic, B-Cell 154 Lymphoma, Large B-Cell, Diffuse 133 Lymphoma, Follicular 131 Lymphoma, Mantle-Cell 93 Leukemia 68 Lymphoma, B-Cell, Marginal Zone 66 Waldenstrom Macroglobulinemia 49 Burkitt Lymphoma 43 Lymphoma, B-Cell 40 Precursor Cell Lymphoblastic Leukemia-Lymphoma 36 Hodgkin Disease 36 Recurrence 24 Lymphoma, Large-Cell, Immunoblastic 24 Neoplasms 15 Myelodysplastic Syndromes 15 Lymphoma, Large-Cell, Anaplastic 15 Multiple Myeloma 13 Leukemia, Myeloid, Acute 12 Lymphoma, T-Cell, Cutaneous 9 Lymphoma, Extranodal NK-T-Cell 9 Leukemia, Hairy Cell 9 Intraocular Lymphoma 9 Hematologic Neoplasms 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Immunoblastic Lymphadenopathy 8 Sezary Syndrome 7 Mycosis Fungoides 7 Lymphoma, T-Cell 7

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 pembrolizumab 1 ioflupane 1 idelalisib 1 aflibercept 1 Water 1 Vertical Dimension 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡